↓ Skip to main content

Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil

Overview of attention for article published in Genetics and Molecular Biology, June 2016
Altmetric Badge

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
64 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil
Published in
Genetics and Molecular Biology, June 2016
DOI 10.1590/1678-4685-gmb-2014-0363
Pubmed ID
Authors

Palmero, Edenir Inêz, Alemar, Bárbara, Schüler-Faccini, Lavínia, Hainaut, Pierre, Moreira-Filho, Carlos Alberto, Ewald, Ingrid Petroni, Santos, Patricia Koehler dos, Ribeiro, Patricia Lisbôa Izetti, Oliveira Netto, Cristina Brinkmann de, Calvez-Kelm, Florence Le, Tavtigian, Sean, Cossio, Silvia Liliana, Giugliani, Roberto, Caleffi, Maira, Ashton-Prolla, Patricia, Palmero, Edenir Inêz, Alemar, Bárbara, Schüler-Faccini, Lavínia, Hainaut, Pierre, Moreira-Filho, Carlos Alberto, Ewald, Ingrid Petroni, Santos, Patricia Koehler dos, Ribeiro, Patricia Lisbôa Izetti, Oliveira Netto, Cristina Brinkmann de, Calvez-Kelm, Florence Le, Tavtigian, Sean, Cossio, Silvia Liliana, Giugliani, Roberto, Caleffi, Maira, Ashton-Prolla, Patricia

Abstract

In Brazil, breast cancer is a public health care problem due to its high incidence and mortality rates. In this study, we investigated the prevalence of hereditary breast cancer syndromes (HBCS) in a population-based cohort in Brazils southernmost capital, Porto Alegre. All participants answered a questionnaire about family history (FH) of breast, ovarian and colorectal cancer and those with a positive FH were invited for genetic cancer risk assessment (GCRA). If pedigree analysis was suggestive of HBCS, genetic testing of the BRCA1, BRCA2, TP53, and CHEK2 genes was offered. Of 902 women submitted to GCRA, 214 had pedigrees suggestive of HBCS. Fifty of them underwent genetic testing: 18 and 40 for BRCA1/BRCA2 and TP53 mutation screening, respectively, and 7 for CHEK2 1100delC testing. A deleterious BRCA2 mutation was identified in one of the HBOC probands and the CHEK2 1100delC mutation occurred in one of the HBCC families. No deleterious germline alterations were identified in BRCA1 or TP53. Although strict inclusion criteria and a comprehensive testing approach were used, the suspected genetic risk in these families remains unexplained. Further studies in a larger cohort are necessary to better understand the genetic component of hereditary breast cancer in Southern Brazil.

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 64 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 17%
Researcher 9 14%
Student > Bachelor 5 8%
Student > Doctoral Student 5 8%
Student > Ph. D. Student 4 6%
Other 11 17%
Unknown 19 30%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 18 28%
Medicine and Dentistry 12 19%
Agricultural and Biological Sciences 9 14%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Sports and Recreations 1 2%
Other 3 5%
Unknown 19 30%